Study | Exclusion reasons | Rmk | Reference |
---|---|---|---|
Rotem - Miconazole (Vaginal), 2018 | repeat population groups, duplicate reports (most recent study included) | EXCLUDED: 2 local azoles were assessed in this study using the same database: to avoid redundancy of controls, only 1 was used, this one with more exposed pregnancies (i.e Clotrimazole). | |
Czeizel - Econazole (Vaginal), 2003 | repeat population groups, duplicate reports (most recent study included) | EXCLUDED: Database analyzing several local azoles => to avoid redundancy of cases and controls, only 1 substance was reported here, this one with the most exposed cases. |
Czeizel Eur. J. Obstet. Gynecol. Reprod. Biol. 2003; 111:135-40 10.1016/s0301-2115(03)00192-1 |
Vermes - Clotrimazole, 2015 | repeat population groups, duplicate reports (most recent study included) | EXCLUDED: Study analysis several local azoles => to avoid redundancy of cases and controls, only 1 substance was reported here, this one with the most exposed cases, Kazy 2005b. |
Vermes Birth Defects Res. Part A Clin. Mol. Teratol. 2015; 103:804-13 10.1002/bdra.23383 |
Czeizel - Miconazole (Topical), 2004 | repeat population groups, duplicate reports (most recent study included) | EXCLUDED: This database (HCCSCA) was used several times to assess local azole (Czeizel 2004, Czeizezl 1999, Kazy 2005)...: to avoid redundancy of cases and controls, only 1 was used, this one with more exposed cases. |
Czeizel Congenit Anom (Kyoto) 2004; 44:41-5 10.1111/j.1741-4520.2004.00007.x |
Kazy c - Metronidazole and miconazole (Vaginal), 2005 | repeat population groups, duplicate reports (most recent study included) | EXCLUDED: This database (HCCSCA) was used several times to assess local azole (Czeizel 2004, Czeizezl 1999, Kazy 2005)...: to avoid redundancy of cases and controls, only 1 was used, this one with more exposed cases. |
Kazy Reprod Toxicol 2005; 20:89-94 10.1016/j.reprotox.2004.11.012 |